Close to 600 tuberculosis (TB) patients will be out in the cold by the end of this month as Penduka Namibia shuts its doors because funding has died up.

According to a report released during the Tuberculosis (TB) and Human immunodeficiency virus (HIV) seminar in Gauteng, more than 81% of people who were screened, tested and diagnosed with TB in the province's public health facilities have been cured.

A research team from the National University of Singapore (NUS) Singapore Lipidomics Incubator (SLING) is collaborating with the Foundation for Innovative New Diagnostics (FIND) to identify novel target molecules to be employed as biomarkers for the detection of active tuberculosis (TB). The aim is to translate these targets into a diagnostic test that is affordable, easy to use and produces rapid results, and that can be used by community health workers in poor countries.

When microbes divide, you usually get more of the same: A cell splits up and creates two identical copies of itself. But a new study shows that's not true for mycobacteria, which cause tuberculosis (TB) in humans—and that may explain why the disease is so difficult to treat. Mycobacteria divide asymmetrically, generating a population of cells that grow at different rates, have different sizes, and differ in how susceptible they are to antibiotics, increasing the chances that at least some will survive. Researchers hope the findings will help them develop drugs against those cells that are especially hard to kill.

Boston, MA — A new study led by Harvard School of Public (HSPH) researchers provides a novel explanation as to why some tuberculosis cells are inherently more difficult to treat with antibiotics. The discovery, which showed that the ways mycobacteria cells divide and grow determine their susceptibility to treatment with drugs, could lead to new avenues of drug development that better target tuberculosis cells.

University of Birmingham academics from the School of Biosciences are joining forces with peers from the Indian Institute of Science, Bangalore (IISc) in a new research partnership focused on tackling tuberculosis (TB).

South Africa is currently burdened with one of the world’s worst Tuberculosis (TB) epidemics, despite its relative wealth, strong health care system, and commitment to combating the disease. Within a population of 50 million, approximately 400,000 new cases are reported each year (World Health Organization (WHO), 2011). 

The Global Fund to Fight AIDS, Tuberculosis and Malaria released an “Information Note” explaining the Transitional Funding Mechanism (TFM) that the Fund Board recently decided would replace a Round 11 funding cycle. The information note and accompanying documentation are meant to aid applicants in the development of proposals for TFM funding.

Research and Markets (http://www.researchandmarkets.com/research/ae82e3/tuberculosis_infec) has announced the addition of GlobalData's new report "Tuberculosis Infection - Pipeline Assessment and Market Forecasts to 2018" to their offering.

Washington — The Millennium Challenge Corporation (MCC), through its partnership with the Millennium Challenge Account-Lesotho, is helping Lesotho address key challenges in its health sector through a $122 million investment in health infrastructure and health systems.